欧洲药物基因组学市场预测至 2028 年 - COVID-19 影响和区域分析技术（PCR、测序、微阵列、凝胶电泳、质谱等）、应用（药物发现、肿瘤学、神经病学和精神病学、疼痛管理、心血管疾病、等）和最终用户（医院和诊所、生物制药公司、CRO 和 CDMO 等）
No. of Pages: 171 | Report Code: TIPRE00028855 | Category: Life Sciences
No. of Pages: 171 | Report Code: TIPRE00028855 | Category: Life Sciences
推动该市场增长的关键因素是慢性病患病率不断上升、精准医疗需求激增以及资助药物基因组学研究活动。然而，熟练专业人员的短缺预计将限制预测期内的市场增长。
基因组测序越来越多地应用于临床实践，在未来五年内，基因组测序将越来越多地应用于临床实践。预计医疗保健系统将生成来自超过 6000 万患者的数据。药物基因组学正在迅速过渡到临床实践，并且在至少 14 个国家的政府投资支持下，在医疗保健系统中的实施总额超过 40 亿美元。这些国家基因组医学计划在现实生活条件下推动变革，同时解决实施障碍并收集证据以供更广泛采用。
英国宣布了世界上最大的基因组医学计划基因组计划是慈善机构和制药公司之间 2 亿欧元公私合作的一部分。作为英国研究与创新的一部分，英国已经通过创新英国领导的 100,000 个基因组项目开发了世界上最大的基因组数据库。它将资助研究人员和行业将英国医疗保健服务的数据和现实证据相结合，创造出更有效地诊断疾病的新产品和服务。
2018 年 11 月，Stilla Technologies 宣布已完成由 Illumina Ventures 领投的 1830 万美元（1600 万欧元）A 轮融资。该公司计划利用这笔资金将其 Naica 数字 PCR 系统商业化并开发临床应用。
基因组学领域制造商和政府的持续资助正在推动欧洲药物基因组学市场.
Strategic insights for Europe Pharmacogenomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,962.48 Million |
| Market Size by 2028 | US$ 3,874.31 Million |
| Global CAGR (2021 - 2028) | 10.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Pharmacogenomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Pharmacogenomics Market is valued at US$ 1,962.48 Million in 2021, it is projected to reach US$ 3,874.31 Million by 2028.
As per our report Europe Pharmacogenomics Market, the market size is valued at US$ 1,962.48 Million in 2021, projecting it to reach US$ 3,874.31 Million by 2028. This translates to a CAGR of approximately 10.2% during the forecast period.
The Europe Pharmacogenomics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pharmacogenomics Market report:
The Europe Pharmacogenomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Pharmacogenomics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Pharmacogenomics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Pharmacogenomics Market
